01—Abstract
Summary
Summary of the 10-Q filed April 30, 2026. Cited figures are marked; the original filing is the authoritative source.
Fortive Corporation reported first-quarter 2026 results for the three months ended April 3, 2026, with total sales of $1,069.4 milliona, up from $993.1 million a year earlier, and net earnings from continuing operations of $136.4 million, up from $112.6 million.
Diluted EPS from continuing operations was $0.44b, compared with $0.33. Operating profit rose to $191.7 million from $165.3 million, and the operating profit margin was 17.9% versus 16.6%. Reported total revenue growth was 7.7%, which included a 2.4% currency benefit and a core revenue growth of 5.3%.
Net earnings for the prior-year period included $59.3 millionc from discontinued operations related to the Ralliant separation, so total net earnings fell to $136.4 million from $171.9 million. Cash generation was steady, with operating cash flow from continuing operations of $220.4 million, up from $191.8 million. Fortive returned capital aggressively: it repurchased 8.9 million shares for about $500 million, paid $18.4 million in dividends, and repaid the $292.9 million 3.7% Euro notes due 2026 largely with commercial paper.
Commercial paper borrowings rose to $1,241.1 milliond, and total long-term debt principal reached $3,497.4 million, compared with $3,213.5 million at year-end 2025. Cash and equivalents were $356.1 million. On March 17, 2026, the company amended its $2.0 billion revolving credit facility, extending its availability to March 17, 2031, and no borrowings were outstanding under it.
Segment results showed Intelligent Operating Solutions sales of $743.2 million with operating profit of $186.2 million, and Advanced Healthcare Solutions sales of $326.2 million with operating profit of $32.7 million, up from $21.7 million. Remaining performance obligations totaled $839.9 million. Remaining authorization was 6.6 million shares under the general repurchase program and $67.5 million under the special program funded by Ralliant proceeds.
02—Key points
Key Highlights
- Total sales rose to $1,069.4 million from $993.1 million, with core revenue growth of 5.3% (non-GAAP) and currency adding to reported growth of 7.7%.
- Operating profit increased to $191.7 million from $165.3 million, with operating margin of 17.9% versus 16.6%.
- Diluted EPS from continuing operations was $0.44, compared with $0.33 in the prior-year quarter.
- Fortive repurchased 8.9 million shares for approximately $500 million and paid $18.4 million in dividends during the quarter.
- Commercial paper borrowings increased to $1,241.1 million from $650.0 million at December 31, 2025, and the company repaid $292.9 million of 3.7% Euro notes due 2026.
- Advanced Healthcare Solutions operating profit rose to $32.7 million from $21.7 million, while Intelligent Operating Solutions operating profit was $186.2 million.
- The revolving credit facility was amended on March 17, 2026, extending availability to March 17, 2031; no borrowings were outstanding at quarter end.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q2 FY2026, Fortive kept $0.13.
- Revenue$1.07B100.0%
- Cost of revenue−$393.9M36.8%
- Gross profit$675.5M63.2%
- Operating costs−$483.8M45.2%
- Operating income$191.7M17.9%
- Interest, other & tax−$55.3M5.2%
- Net income$136.4M12.8%
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2026filed April 30, 2026Financial Statements
Q2 FY2026 against Q2 FY2025
| Line item | Q2 FY2026Q2 FY2025 | Change |
|---|---|---|
| Revenue | $1.07B$1.02B | +5.2% |
| Cost of Revenue | $393.90M$370.90M | +6.2% |
| Gross Profit | $675.50M$645.50M | +4.6% |
| R&D Expenses | $66.50M$67.20M | −1.0% |
| SG&A Expenses | $417.30M$408.50M | +2.2% |
| Operating Expenses | -$483.80M-$475.70M | −1.7% |
| Operating Income | $191.70M$169.80M | +12.9% |
| Interest Expense | -$31.60M-$32.10M | +1.6% |
| Net Income | $136.40M$166.60M | −18.1% |
| EPS (Basic) | $0.44$0.49 | −10.2% |
| EPS (Diluted) | $0.44$0.49 | −10.2% |
| Shares Outstanding (Basic) | 309.60M339.60M | −8.8% |
| Shares Outstanding (Diluted) | 312.80M341.70M | −8.5% |
05—Questions
Frequently Asked Questions
How did Fortive's revenue and profitability change in the first quarter of 2026?
Total sales were $1,069.4 million, up from $993.1 million. Operating profit was $191.7 million versus $165.3 million, and net earnings from continuing operations were $136.4 million versus $112.6 million. Diluted EPS from continuing operations was $0.44 compared with $0.33.
What drove the sales growth?
The company cited favorable pricing of 2.2% and volume growth of 3.1%, partly due to additional selling days, plus favorable foreign currency translation. Core revenue growth excluding currency and acquisitions was 5.3%.
How is Fortive managing its capital and debt?
Fortive repurchased 8.9 million shares for about $500 million and paid $18.4 million in dividends. It funded these uses and the repayment of $292.9 million of Euro notes largely through $591.7 million of net commercial paper borrowings. Total debt principal rose to $3,497.4 million, and the company said it was in compliance with its credit agreement covenants.
How much liquidity does Fortive have?
The company held $356.1 million in cash and equivalents at April 3, 2026, and a $2.0 billion revolving credit facility that supports commercial paper, with no borrowings outstanding. Management stated it expects sufficient liquidity for the foreseeable future.
What remains under the share repurchase authorizations?
As of April 3, 2026, 6.6 million shares remained under the General Share Repurchase Program and $67.5 million remained under the Special Share Repurchase Program, which is funded by proceeds received from Ralliant.
06—Continue